-
Karyopharm Therapeutics' (KPTI) Outperform Rating Reaffirmed at Royal Bank of Canada
Source: Buzz FX / 10 Feb 2025 11:46:10 America/Chicago
Karyopharm Therapeutics' (KPTI) Outperform Rating Reaffirmed at Royal Bank of Canada Written by MarketBeat February 10, 2025 Share Link copied to clipboard. Karyopharm Therapeutics ( NASDAQ:KPTI - Get Free Report ) 's stock had its "outperf
Read more...